Hong Kong Pharmaceuticals & Healthcare Views

Pages

Asia Pacific Remains Highly Attractive

Geographic diversification may be a favourable strategy for multinational pharmaceutical companies, but it is vital that firms recognise both the rewards and the risks present in a market, whether...

Read article ›
OrbusNeich Launches Dual Therapy Stent

OrbusNeich has introduced the Combo dual therapy stent, believed to be the world’s first dual therapy stent to address delayed healing of the coronary artery associated with monotherapy drug...

Read article ›

Pages